Search

everythinglearnresearchcommunity

for

Search:↓

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

A DNA aptamer helps promote hair growth by enhancing a key cell growth signal in hair follicle cells.

Get3d protein helps maintain photosynthesis in plants and photosynthetic bacteria.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Drugs that block GSK-3 show promise for treating various diseases.

Topical IKKα inhibitors may help prevent CCS tumours.

Quercitrin may help treat Alzheimer's by boosting brain cell signaling without causing tumors.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Promising cancer treatments were found, but the manufacturer closed.

Researchers developed a scaffold that releases a healing drug over time, improving wound healing and skin regeneration.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

The compound 4c showed strong potential as an anticancer agent.

Entospletinib effectively prevents eye and skin GVHD in mice.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

LGD1069 effectively prevents breast tumors in mice without toxicity.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.